Multiple Roles for Cysteine Cathepsins in Cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cell Cycle

• Publication date

  2004-09-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/cc.3.12.1289PMID 15539953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer.

  2004cited by this paper
• Cathepsin B Mediates Caspase-Independent Cell Death Induced by Microtubule Stabilizing Agents in Non-Small Cell Lung Cancer Cells

  2004cited by this paper
• Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis.

  2004cited by this paper
• Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis

  2004cited by this paper
• A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor.

  2004cited by this paper
• Adenovirus-Mediated Expression of Antisense Urokinase Plasminogen Activator Receptor and Antisense Cathepsin B Inhibits Tumor Growth, Invasion, and Angiogenesis in Gliomas

  2004cited by this paper
• Pericellular cathepsin B and malignant progression

  2003cited by this paper
• Deficiency of the Cysteine Protease Cathepsin S Impairs Microvessel Growth

  2003cited by this paper
• Molecular mechanisms of glioma invasiveness: the role of proteases

  2003cited by this paper
• Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro.

  2003cited by this paper
• Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter

  2003cited by this paper
• Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis.

  2003cited by this paper
• Surface Cathepsin B Protects Cytotoxic Lymphocytes from Self-destruction after Degranulation

  2002cited by this paper
• Interaction of Human Breast Fibroblasts with Collagen I Increases Secretion of Procathepsin B*

  2002cited by this paper
• Phorbol Ester Activation of a Proteolytic Cascade Capable of Activating Latent Transforming Growth Factor-β

  2002cited by this paper
• Decreased intracellular degradation of insulin‐like growth factor binding protein‐3 in cathepsin L‐deficient fibroblasts

  2002cited by this paper
• Neuronal loss and brain atrophy in mice lacking cathepsins B and L

  2002cited by this paper
• Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer.

  2002cited by this paper
• An intracellular form of cathepsin B contributes to invasiveness in cancer.

  2001cited by this paper
• Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells

  2001cited by this paper
• Cathepsin B Acts as a Dominant Execution Protease in Tumor Cell Apoptosis Induced by Tumor Necrosis Factor

  2001cited by this paper
• Cysteine Proteinases Mediate Extracellular Prohormone Processing in the Thyroid

  2001cited by this paper
• Towards Specific Functions of Lysosomal Cysteine Peptidases: Phenotypes of Mice Deficient for Cathepsin B or Cathepsin L

  2001cited by this paper
• Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c.

  2000cited by this paper
• Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor.

  2000cited by this paper
• Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis.

  2000cited by this paper
• Generation and degradation of human endostatin proteins by various proteinases

  2000cited by this paper
• Secreted cathepsin L generates endostatin from collagen XVIII

  2000cited by this paper
• Human Procathepsin B Interacts with the Annexin II Tetramer on the Surface of Tumor Cells*

  2000cited by this paper
• Cathepsin B and glioma invasion

  1999cited by this paper
• Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line.

  1999cited by this paper
• Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors.

  1999cited by this paper
• Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases

  1999cited by this paper
• Cysteine proteinases in cancer progression and their clinical relevance for prognosis.

  1998cited by this paper
• Cathepsin B and human tumor progression.

  1998cited by this paper
• Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice.

  1996cited by this paper
• Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples.

  1994cited by this paper
• Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.

  1985cited by this paper
• Release of cathepsin B precursors from human and murine tumours.

  1985cited by this paper
• Secretion of a cysteine proteinase from a hormone-independent cell population of cultured explants of murine mammary gland.

  1985cited by this paper

• CATHEPSIN D: MOLECULAR, GENETIC AND FUNCTIONAL ASPECTS IN THE TUMOR MICROENVIRONMENT

  2026cites this paper
• Cathepsins and age-related macular degeneration: A Mendelian randomization study unveiling causal relationships

  2025cites this paper
• Molecular Underpinnings of Brain Metastases

  2025cites this paper
• Cathepsin C in health and disease: from structural insights to therapeutic prospects

  2024cites this paper
• Investigation of CST7 and hsa-miR-4793-5p gene expression in breast cancer

  2024cites this paper
• Role of proteases in oral carcinogenesis: Insights into the cancer degradome and therapeutic implications

  2024cites this paper
• Proteases: Role in Various Human Diseases.

  2024cites this paper
• Impact of the Recognition Part of Dipeptidyl Nitroalkene Compounds on the Inhibition Mechanism of Cysteine Proteases Cruzain and Cathepsin L

  2023cites this paper
• Lysosomes as a Target of Anticancer Therapy

  2023cites this paper
• A Computational Approach for Exploring Indinavir as a Potent Protease Inhibitor and Development of Its Microsphere for Anticancer Activity

  2023cites this paper
• Non-degradable autophagic vacuoles are indispensable for cell competition.

  2022cites this paper
• Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug

  2022cites this paper
• Multifunctional stimuli-responsive hybrid nanogels for cancer therapy: Current status and challenges.

  2022cites this paper
• Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma

  2022cites this paper
• In Silico, In Vitro, and Clinical Investigations of Cathepsin B and Stefin A mRNA Expression and a Correlation Analysis in Kidney Cancer

  2022cites this paper
• Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands

  2021cites this paper
• Formulation and Evaluation of Isradipine Nanosuspension and Exploring its Role as a Potential Anticancer Drug by Computational Approach.

  2021cites this paper
• Cathepsin C inhibitors as anti-inflammatory drug discovery: Challenges and opportunities.

  2021cites this paper
• Cathepsins B, D, and G Are Expressed in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma

  2021cites this paper
• Preliminary Correlation of the Immunoexpression of Cathepsin B and E-Cadherin Proteins in Vocal Fold Leukoplakia.

  2021cites this paper
• Development and Validation of a Novel Immune-Related Prognostic Model and the Potential Mechanism in Metastatic Synovial Sarcoma

  2021cites this paper
• Decursin inhibits cell growth and autophagic flux in gastric cancer via suppression of cathepsin C.

  2021cites this paper
• The role of endolysosomal trafficking in anticancer drug resistance.

  2021cites this paper
• Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview

  2021cites this paper
• Monocyclic beta–lactams for therapeutic uses: a patent overview (2010–2020)

  2020cites this paper
• Praeruptorin B Mitigates the Metastatic Ability of Human Renal Carcinoma Cells through Targeting CTSC and CTSV Expression

  2020cites this paper
• Studies on cysteine proteases and their inhibitors for anticancer drug design

  2020cites this paper
• Tumor cell- and microenvironment-specific roles of cysteine cathepsins in mouse models of human cancers.

  2020cites this paper
• Serine proteases in ovarian cancer

  2020cites this paper
• A Review of Small Molecule Inhibitors and Functional Probes of Human Cathepsin L

  2020cites this paper
• Tumor-suppressive proteases revisited: Role in inhibiting tumor progression and metastasis

  2020cites this paper
• Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model

  2019cites this paper
• Application of nanotechnology to target and exploit tumour associated proteases.

  2019cites this paper
• Nitroxoline: repurposing its antimicrobial to antitumor application.

  2019cites this paper
• Anti-Cancer Effects of Oleocanthal and Extra Virgin Olive Oil

  2019cites this paper
• Organoruthenated Nitroxoline Derivatives Impair Tumor Cell Invasion through Inhibition of Cathepsin B Activity

  2019cites this paper
• (-)-Oleocanthal and (-)-oleocanthal-rich olive oils induce lysosomal membrane permeabilization in cancer cells

  2019cites this paper
• Can Cysteine Protease Cross-class Inhibitors Achieve Selectivity?

  2019cites this paper
• Activation of Viruses by Host Proteases

  2019cites this paper
• Enhanced tumor retention of NTSR1-targeted agents by employing a hydrophilic cysteine cathepsin inhibitor.

  2019cites this paper
• Cathepsin B: Active site mapping with peptidic substrates and inhibitors.

  2019cites this paper
• Coordination geometry-induced optical imaging of l-cysteine in cancer cells using imidazopyridine-based copper(ii) complexes.

  2019cites this paper
• Interaction of tumor-associated macrophages and cancer chemotherapy

  2019cites this paper
• Cathepsin C Interacts with TNF-α/p38 MAPK Signaling Pathway to Promote Proliferation and Metastasis in Hepatocellular Carcinoma

  2019cites this paper
• Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis.

  2019cites this paper
• Cell penetrable, clickable and tagless activity-based probe of human cathepsin L.

  2019cites this paper
• Targeting of cathepsin C induces autophagic dysregulation that directs ER stress mediated cellular cytotoxicity in colorectal cancer cells.

  2018cites this paper
• Increasing time on target: utilization of inhibitors of cysteine cathepsins to enhance the tumor retention of receptor-targeted agents.

  2018cites this paper
• Characterization and Quantification of Covalent Modification of Proteins Using Mass Spectrometry

  2018cites this paper
• Synthesis and biological evaluation of novel synthetic chalcone derivatives as anti-tumor agents targeting Cat L and Cat K.

  2018cites this paper
• Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog 177Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?

  2018cites this paper
• Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation

  2018cites this paper
• Defining the Determinants of Specificity of Plasmodium Proteasome Inhibitors.

  2018cites this paper
• The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer.

  2018cites this paper
• EUS-FNA cytological material from pancreatic lesions: the expression of cathepsins and its predictive value of malignancy.

  2018cites this paper
• Affinity-Enhanced Luminescent Re(I)- and Ru(II)-Based Inhibitors of the Cysteine Protease Cathepsin L.

  2018cites this paper
• Cysteine cathepsins as a prospective target for anticancer therapies-current progress and prospects.

  2018cites this paper
• Host Cell Proteases: Cathepsins

  2018cites this paper
• Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.

  2018cites this paper
• Cathepsin proteases in human breast cancer cell lines: Expression analysis and targeting by CRISPR/Cas9

  2018cites this paper
• Protease, an Advance Therapeutic Target in Cancer

  2017cites this paper
• Snail-Cathepsin L Signaling in Human Breast and Prostate Cancers

  2017cites this paper
• Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents.

  2017cites this paper
• A comparative account of sar studies of semicarbazones and thiosemicarbazones on cathepsins H and L

  2017cites this paper
• A Highly Selective and Efficient Copper(II) – “Turn‐On” Fluorescence Imaging Probe for l‐Cysteine

  2017cites this paper
• Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo

  2017cites this paper
• Effects of Vacuolar H+-ATPase Inhibition on Activation of Cathepsin B and Cathepsin L Secreted from MDA-MB231 Breast Cancer Cells

  2017cites this paper
• Copper(ii)-benzimidazole complexes as efficient fluorescent probes for l-cysteine in water.

  2017cites this paper
• Cathepsins in digestive cancers

  2017cites this paper
• Role of protease and protease inhibitors in cancer pathogenesis and treatment.

  2017cites this paper
• Role of Proteases in Regulating Cell Death Pathways

  2017cites this paper
• Lysosome and Cancer

  2016cites this paper
• Clioquinol-ruthenium complex impairs tumour cell invasion by inhibiting cathepsin B activity.

  2016cites this paper
• Multitriggered Tumor-Responsive Drug Delivery Vehicles Based on Protein and Polypeptide Coassembly for Enhanced Photodynamic Tumor Ablation.

  2016cites this paper
• Proton Pump Inhibitors and Melanocytes

  2016cites this paper
• Procathepsin E is highly abundant but minimally active in pancreatic ductal adenocarcinoma tumors

  2016cites this paper
• Inhibition of endopeptidase and exopeptidase activity of cathepsin B impairs extracellular matrix degradation and tumour invasion

  2016cites this paper
• Study of the expression of cathepsins in histological material from pancreatic lesions.

  2016influential citation
• Diagnostic values of serum cathepsin B and D in patients with nasopharyngeal carcinoma

  2016cites this paper
• Expression profile of cathepsins indicates the potential of cathepsins B and D as prognostic factors in breast cancer patients

  2015cites this paper
• Different Preference of Degradome in Invasion versus Angiogenesis

  2015cites this paper
• The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma

  2015cites this paper
• Micrometastatic Circulating Tumor cells - A Challenge for an Early Detection and Better Survival Rates

  2015cites this paper
• Development of novel anti-cancer prodrug strategies

  2015cites this paper
• Increased expression of transcription factor EB (TFEB) is associated with autophagy, migratory phenotype and poor prognosis in non-small cell lung cancer.

  2015cites this paper
• Electron transfer and reaction mechanism of laccases

  2015cites this paper
• p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3

  2015cites this paper
• Proteolysis mediated by cysteine cathepsins and legumain—recent advances and cell biological challenges

  2015cites this paper
• IGF-1 promotes the growth and metastasis of hepatocellular carcinoma via the inhibition of proteasome-mediated cathepsin B degradation.

  2015cites this paper
• Development of Cell-Active Inhibitors and Activity-Based Probe of Cysteine Cathepsins

  2014cites this paper
• Predicting patient-to-patient variability in proteolytic activity and breast cancer progression

  2014cites this paper
• Cell–matrix interactions: focus on proteoglycan–proteinase interplay and pharmacological targeting in cancer

  2014cites this paper
• Lysosomes and Nanotherapeutics: Diseases, Treatments, and Side Effects

  2014cites this paper
• The current stage of cathepsin B inhibitors as potential anticancer agents.

  2014cites this paper
• Cathepsins mediate tumor metastasis World Journal of Biological Chemistry

  2013cites this paper
• Cancer-associated lysosomal changes: friends or foes?

  2013cites this paper
• carcinogenesis Cathepsin C is a tissue-specific regulator of squamous Material

  2013cites this paper
• Molecular Functions of Thyroid Hormones and Their Clinical Significance in Liver-Related Diseases

  2013cites this paper
• Predictive Biomarkers for Antibody–Drug Conjugates

  2013cites this paper
• Multivalent Cathepsin Inhibitor, VBY-825, Attenuates Breast-Induced Bone Cancer Remodelling and Pain

  2013influential citation